lynestrenol has been researched along with Prostatic Hyperplasia in 1 studies
Lynestrenol: A synthetic progestational hormone used often in mixtures with estrogens as an oral contraceptive (CONTRACEPTIVES, ORAL).
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scultéty, S | 1 |
| Sas, M | 1 |
| Varga, B | 1 |
1 trial available for lynestrenol and Prostatic Hyperplasia
| Article | Year |
|---|---|
[Studies using synthetic progestogens in drug therapy of so-called prostatic hypertrophy].
Topics: 17-Ketosteroids; Aged; Clinical Trials as Topic; Estrogens; Humans; Hydroxyprogesterones; Lynestreno | 1973 |